<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.1-a.5'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/sindrome-coronario-agudo-2025-las-tres-cosas-que-hay-que-dejar-de-hacer-y-las-cinco-que-hay-que-empezar/</loc>
  <lastmod>2026-07-30T03:27:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Síndrome coronario agudo 2025: las tres cosas que hay que dejar de hacer y las cinco que hay que empezar</news:title>
   <news:publication_date>2026-07-30T03:27:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/del-visitador-con-vocacion-cientifica-al-socio-estrategico-historia-y-evolucion-del-msl-en-la-industria-farmaceutica/</loc>
  <lastmod>2026-07-30T03:23:40Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Del visitador con vocación científica al socio estratégico: historia y evolución del MSL en la industria farmacéutica</news:title>
   <news:publication_date>2026-07-30T03:23:40Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/antecedentes-familiares-arbol-genealogico/</loc>
  <lastmod>2026-07-29T22:14:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Antecedentes familiares: árbol genealógico cardiometabólico</news:title>
   <news:publication_date>2026-07-29T22:14:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/eeuu-210-fibra-colesterol-glucosa/</loc>
  <lastmod>2026-07-29T16:19:58Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Fibra: el nutriente subestimado para bajar el colesterol y la glucosa (2026)</news:title>
   <news:publication_date>2026-07-29T16:19:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/insuficiencia-cardiaca-segunda-definicion-universal-2026/</loc>
  <lastmod>2026-07-29T11:20:22Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Insuficiencia cardíaca: qué cambió con la Segunda Definición Universal 2026 (y qué haces distinto mañana)</news:title>
   <news:publication_date>2026-07-29T11:18:32Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/29/glucosa-en-ayunas-alterada-vs-intolerancia-glucosa/</loc>
  <lastmod>2026-07-29T11:21:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Glucosa en ayunas alterada vs. intolerancia a la glucosa: diferencias y qué hacer (2026)</news:title>
   <news:publication_date>2026-07-29T11:15:02Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/28/antecedentes-patologicos-10-cambian/</loc>
  <lastmod>2026-07-28T22:13:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Antecedentes patológicos: 10 que cambian el diagnóstico</news:title>
   <news:publication_date>2026-07-28T22:13:55Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/28/eeuu-209-probioticos-evidencia-marketing/</loc>
  <lastmod>2026-07-28T16:20:59Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Probióticos en 2026: cuáles tienen evidencia y cuáles son puro marketing (guía EE.UU.)</news:title>
   <news:publication_date>2026-07-28T16:20:59Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/28/entre-colegas-omeprazol-profilaxis-rutina/</loc>
  <lastmod>2026-07-28T12:25:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Entre colegas &amp;#124; 💊 «A todos les pongo su omeprazolito, doctor… por si las moscas»</news:title>
   <news:publication_date>2026-07-28T12:25:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/07/28/prediabetes-momento-ideal-para-actuar/</loc>
  <lastmod>2026-07-28T11:13:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prediabetes: el momento ideal para actuar (guía 2026)</news:title>
   <news:publication_date>2026-07-28T11:13:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
